Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carnival Corp (CCL) Jumps This Morning On Deutsche Bank Upgrade: Is It Time To Buy?

Page 1 of 2

Carnival Corporation (NYSE:CCL) jumped to $50.48 per share upon the opening of the markets today, a marked improvement from its close of $48.88 per share on Friday, June 19. The gains have come largely on the back of a rating upgrade from Deutsche Bank. In a note to clients this morning, Deutsche Bank analyst Richard Carter revised Carnival Corporation’s rating to ‘Buy’ from a previous rating of ‘Hold’. The analyst also reported a major change in the investment bank’s price target on Carnival Corporation, from $55.30 from $51.00, suggesting remaining short-term upside of over 10%. According to Carter, Deutsche Bank expects Carnival Corp (NYSE:CCL)’s second quarter earnings to be “above the upper end of its guidance range” and that the group will show more “bookings and pricing recovery coupled with more operational momentum in its core Carnival brand.” Furthermore, Carter says that this update on the company is expected to “incrementally build confidence” in the company for the longer term and not only in the short term. Deutsche Bank expects EPS for the second quarter of the year to improve to $0.17  from $0.14 in the same year-ago quarter, on sustained operating efficiencies and lower fuel costs. The rosy outlook on Carnival Corporation (NYSE:CCL) comes amid there also being an increase in hedge fund interest of late among the hedge funds tracked by Insider Monkey.

 Carnival Corp (CCL), NYSE:CCL,

First, a quick word on why we track hedge fund activity. In 2014, equity hedge funds returned just 1.4%. In 2013, that figure was 11.3%, and in 2012, they returned just 4.8%. These are embarrassingly low figures compared to the S&P 500 ETF (SPY)’s 13.5% gain in 2014, 32.3% gain in 2013, and 16% gain in 2012. Does this mean that hedge fund managers are dumber than a bucket of rocks when it comes to picking stocks? The answer is definitely no. Our small-cap hedge fund strategy – which identifies the best small-cap stock picks of the best hedge fund managers – returned 28.2% in 2014, 53.2% in 2013, and 33.3% in 2012, outperforming the market each year (it’s outperforming it so far in 2015 too). What’s the reason for this discrepancy, you may ask? The reason is simple: size. Hedge funds have gotten so large, they have to allocate the majority of their money into large-cap liquid stocks that are more efficiently priced. They are like mutual funds now. Consider Ray Dalio’s Bridgewater Associates, the largest in the industry with about $165 billion in AUM. It can’t allocate too much money into a small-cap stock as merely obtaining 2% exposure would really move the price. In fact, Dalio can’t even obtain 2% exposure to many small-cap stocks, even if he essentially owned the entire company, as they’re simply too small (or rather, his fund is too big). This is where we come in. Our research has shown that it is actually hedge funds’ small-cap picks that are their best performing ones and we have consistently identified the best picks of the best managers, returning 142% since the launch of our small-cap strategy compared to less than 60% for the S&P 500 (see the details).

In terms of insider sentiment, we see a small sale of shares during the month of May, from Carnival Corporation Director Richard Glasier, who sold 4,000 shares of Carnival Corporation (NYSE:CCL) at the start of the month. There has been no recent insider buying activity.

Now, let’s examine the key hedge fund activity around Carnival Corporation as of late.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!